Real-world analysis of clinical and economic impact of 21-gene recurrence score (RS) testing in early-stage breast cancer (ESBC) in Ireland.
McSorley LM, Tharmabala M, Al Rahbi F, McSorley K, Chew S, Evoy D, Geraghty JG, Prichard RS, Rothwell J, McCartan DP, McDermott EW, Keane M, Kennedy MJ, O'Reilly S, Millen SJ, Crown JP, Smyth LM, Kelly CM, Quinn CM, Walshe JM.
McSorley LM, et al. Among authors: millen sj.
Breast Cancer Res Treat. 2021 Aug;188(3):789-798. doi: 10.1007/s10549-021-06211-w. Epub 2021 Apr 9.
Breast Cancer Res Treat. 2021.
PMID: 33835293